Health Condition 1: O359- Maternal care for (suspected) fetal abnormality and damage, unspecified
Conditions
Interventions
Intervention1: Lignocaine Spray: Lignocaine spray will be applied on maternal abdominal wall before starting of Amniocentesis and pain score will be assesed
Control Intervention1: Normal saline spray:
Sponsors
AIIMS Jodhpur
Eligibility
Inclusion criteria
Inclusion criteria: Singleton pregnancy and gestational age 15-24 weeks based on reliable last menstrual period and/or sonographic biometry in 1st trimester of pregnancy (11 to 13+6 weeks) having following indications- h/o chromosomal abnormality in baby high risk/intermediate risk cases according to aneuploidy results Nuchal translucency >3.5 mm Previous syndromic baby ,parents having balanced translocation,usg suggestive of any structural abnormality
Exclusion criteria
Exclusion criteria: patient having history of lignocaine allrgy inability to rate pain score by visual analogue scale patient refusal abnormal sensory function based on history
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effect of lignocaine spray with placebo on pain perception due to amniocentesis at the time of procedure by VAS and VRSTimepoint: 0 minutes(immediately after the procedure) | — |
Secondary
| Measure | Time frame |
|---|---|
| To document the difference between pain scores after 30 minutes of procedure in the 2 groups To document various indications of amniocentesis and complications associated with it like abortion ,infection,leaking or bleeding pv To document the incidence of aneuploidies in high risk and intermediate risk group To evaluate the overall perception of the procedure To find out the agreement between VAS and VRSTimepoint: Pain perception after 30 minutes of procedure Complications-0 minutes till 2 weeks after procedure Incidence of aneuploidies-3 weeks | — |
Countries
India
Contacts
Public ContactDr Tanya Sharma
AIIMS Jodhpur
Outcome results
None listed